The Alfred

• Weight loss medications on exercise capacity in Pulmonary Arterial Hypertension (PAH) patients

  Collaborator, Phase 2/3, Status unknown, 20 people, 14 Sept 2026

• NCT07481175

  Collaborator, Phase 1, Recruiting, 38 people, 18 Mar 2026

• NCT05668026

  Collaborator, Phase 1/2, Recruiting, 18 people, 29 Dec 2022

• NCT05182931

  Collaborator, Phase 2, Status unknown, 80 people, 10 Jan 2022

• NCT04904536

  Collaborator, Phase 3, Active, not recruiting, 190 people, 27 May 2021

• NCT04074460

  Collaborator, Phase 4, Completed, 169 people, 30 Aug 2019

• NCT03426592

  Collaborator, Phase 2, Completed, 30 people, 8 Feb 2018

• NCT03333278

  Collaborator, Phase 2, Completed, 216 people, 6 Nov 2017

• NCT02500446

  Collaborator, Phase 4, Completed, 40 people, 16 Jul 2015

• NCT02354001

  Phase 4, Completed, 80 people, 3 Feb 2015

• NCT01534026

  Phase 4, Completed, 12 people, 16 Feb 2012

• NCT01481883

  Phase 4, Completed, 13 people, 30 Nov 2011

• NCT01470092

  Phase 4, Completed, 120 people, 11 Nov 2011

• NCT01368068

  Phase 4, Terminated, 2 people, 7 Jun 2011

• NCT01239888

  Phase 1, Status unknown, 15 people, 15 Nov 2010

• NCT00532688

  Collaborator, Phase 2/3, Status unknown, 10 people, 20 Sept 2007

• NCT00505804

  Collaborator, Phase 2, Completed, 20 people, 25 Jul 2007

• NCT00361543

  Phase 4, Completed, 54 people, 8 Aug 2006

• NCT00357006

  Phase 2, Completed, 180 people, 27 Jul 2006

• NCT00206557

  Phase 2, Completed, 60 people, 21 Sept 2005

Sources: anzctr.org.au